International Conferences

Recommended Conferences for Drug discovery

Drug discovery

As per available reports about 43 relevant Journals, 38 Conferences,  30 Workshops are presently dedicated exclusively to drug discovery and about 1269 articles are being published on drug discovery.

Drug discovery and development is the process by which new candidate medications are discovered. It is the process through which potential new medicines are identified.The process of drug discovery will take many steps of process clinical trails, and pharmacogenomics, drug design .

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.  

Scope and Importance:

Drug Discovery Conference provides the scope for opportunities to learn progressed by international scientists and academicians. an explosion of genomic information, which is revolutionizing the way drug discovery takes place. Moreover, new fields have arisen such as pharmacogenetics and pharmacogenomics and are touching the goals and guiding principles of drug design and discovery. 

Drug design  discovery and development is an intense, lengthy and an interdisciplinary endeavor. Drug discovery is mostly portrayed as a linear, consecutive process that starts with target and lead discovery, followed by lead optimization and pre-clinical in vitro and in vivo studies to determine if such compounds satisfy a number of pre-set criteria for initiating clinical development. For the pharmaceutical industry, the number of years to bring a drug from discovery to market is approximately 12-14 years and costing upto $1.2 - $1.4 billion dollars. Traditionally, drugs were discovered by synthesizing compounds in a time-consuming multi-step processes against a battery of in vivo biological screens and further investigating the promising candidates for their pharmacokinetic properties, metabolism and potential toxicity. Such a development process has resulted in high attrition rates with failures attributed to poor pharmacokinetics (39%), lack of efficacy (30%), animal toxicity (11%), adverse effects in humans (10%) and various commercial and miscellaneous factors. Today, the process of drug discovery has been revolutionized with the advent of genomics, proteomics, bioinformatics and efficient technologies like, combinatorial chemistry, high throughput screening (HTS), virtual screening, de novo design, in vitro, in silico ADMET screening and structure-based drug design.

Market Analysis:

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

International symposium and workshops

• 1st International Gazi Pharma Symposium Series to be held from November 12 to 15, 2015 in Antalya, Turkey.
• XII International Pharma Licensing Symposium (XII IPLS)
• International symposium and workshops in November 12, 2014 by New Zealand Drug Foundation
• IV International Symposium on Drug Discovery in July 22th to 24th, 2015 held at the School of Pharmaceutical Sciences (UNESP), Araraquara, São Paulo, Brazil,
• International Symposium on Drug Policy and Public Health on 29 September - 1 October 2014 Istanbul, Turkey

List of Best International Conferences:

• 7^th Bioavailability and Bioequivalence: BA/BE Studies Summit
  August 29-31, 2016 Atlanta, USA
• 8^th  Pharmaceutics and Novel Drug Delivery Systems Conference 
  March 07-09, 2016 Madrid, Spain
• Industrial Pharmacy Conference 
  April 28-29, 2016 Dubai, UAE
• 5^th Global Pharmacovigilance Summit 
  April 25-27, 2016 Dubai, UAE
• Medical Writing and Healthcare Communications Conference 
  April 28-29, 2016 Dubai, UAE
• 2^nd Pharmacology and Ethnopharmacology Conference
  May 02-04, 2016 Chicago, USA
• 4^th European Pharma Congress 
  June 13-15, 2016 Berlin, Germany
• American Pharma Expo 
  June 20-22,2016 New Orleans, USA
• 7^th Annual Pharma Summit 
  June 20-22, 2016 New Orleans, USA
• 6^th Pharmacovigilance Conference Congress 
  August 01-03, 2016 Toronto, Canada
• 3^rd World Congress on Pharmacology 
  August 08-10, 2016 Birmingham, UK
• 2^nd Clinical Trials Conference 
  August 22-24, 2016 Philadelphia, USA
• 2^nd Drug Discovery & Designing Conference 
  Oct 31-Nov 02, 2016 Istanbul, Turkey
• ICPSP 2016: 18^th International Conference on Pharmaceutical Sciences and Pharmacology Jan 21-22,2016 Paris, France
• 29^th Annual Pharmacokinetics for Pharmaceutical Scientist 29 Feb – 4 March 2016 San Francisco, CA
• JP Morgan Annual Healthcare Conference January, 2016
• ASCPT Annual Meeting San Diego, CA Mar 8-12, 2016  
• 29^th Orphan Drugs, Collaborations and Market Access Congress San Diego, United States of America
• 11^th Drug Discovery India 2014 Mumbai, India
• 27^th Re-Entering Antibacterial Drug Development Summit Boston, United States of America
• ICPSP 2016: 18^th International Conference on Pharmaceutical Sciences and Pharmacology Jan 21-22,2016 Paris, France
• 29^th Annual Pharmacokinetics for Pharmaceutical Scientist 29 Feb – 4 March 2016 San Francisco, CA
• JP Morgan Annual Healthcare Conference January, 2016
• ASCPT Annual Meeting San Diego, CA Mar 8-12, 2016    
• 29^th Orphan Drugs, Collaborations and Market Access Congress San Diego, United States of America
• 11^th Drug Discovery India 2014 Mumbai, India
• 27^th Re-Entering Antibacterial Drug Development Summit Boston, United States of America

Associations

• Bioanalytical Focus Group and Ligand Binding Assay
• American Association of Pharmaceutical Scientists (AAPS)
• Royal Netherlands Chemical Society
• The European Bioanalysis Forum
• BEBAC Consultancy Services for Bioequivalence and Bioavailability
• American Thyroid Association
• Generic Pharmaceutical Association
• FDA
• European Generic medicines Association.
• Therapeutics Goods Administration (TGA)
• European Economic Area
• Canadian Generic Pharmaceutical Association (CGPA)
• Bioequivalence and Bioavailability forum
• FDA Office of Surveillance and Epidemiology (formerly Drug Safety)
• Drug Watch
• ORPHANET Parenteral Drug Association
• PharmGKB
• US Food and Drug Administration (FDA)
• American Association for Clinical Chemistry (AACC)
• American Association of Pharmaceutical Scientists (AAPS)
• Clinical Trials Information from National Institutes for Health (NIH)
• National Institute of Standards and Technology (NIST)

Companies :

• Myriad RBM, Inc
• NDI ADRL Inc. dba Diteba
• BioScience Laboratories, Inc.
• Pacific BioLabs (PBL)
• Biological Test Center
• Algorithme Pharma, Inc.
• Gateway Analytical
• Celerion
• Apotex Inc.
• PharmaNet Development Group, Inc
• AstraZeneca
• Accredo Therapeutics
• Actelion Pharmaceuticals US, Inc
• Bayer HealthCare
• CRITICAL CARE
• Cané Medical Technology
• CVS Caremark
• CuraScript
• Fairview Specialty Pharmacy
• Gilead Sciences

This page will be updated regularly.

This page was last updated on April 19, 2024